Page 8 - Tongji Hospital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hospitals Overcrowd in China Amid Surge in COVID-19 Variants and Other Infections

Hospitals Overcrowd in China Amid Surge in COVID-19 Variants and Other Infections
theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.

Fang huaHuang jieLiu rongLiaoning provinceLi meiHector retamalWang kaiHamara shutterstockPatriotic health office of haikouJames gathany centers for diseaseHainan provincial centerChina national bureau for diseaseChinese centerNational bureauDisease controlFushun city

Women with health issues and CKD face complex challenges

Women with health issues and CKD face complex challenges
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesElizabeth hendrenJeffrey bernsChristina wyattNityasree srialluriAnna burgnerGiorgina piccoliNutrition examinationDuke healthVanderbilt university medical centerDuke clinical research instituteJohns hopkins university school of medicineUniversity of angersSunnybrook health sciences centerNational healthGeisinger health system

Chinese Hospitals Treat COVID-19 Infections as Common Cold While Cases Surge

Chinese Hospitals Treat COVID-19 Infections as Common Cold While Cases Surge
theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.

Xiao lushengLuo yaLi yuanhuaChinese communist partyHealth organizationChinese centerCenters for diseaseDepartment of respiratory infectionEpoch timesRespiratory infectionFujian provinceDisease controlMeasures takenNew variantTongji hospitalChina january

Equecabtagene Autoleucel Approved in China for Relapsed/Refractory Multiple Myeloma

China’s National Medical Products Administration has approved the new drug application for equecabtagene autoleucel for the treatment of adult patients with relapsed or refractory multiple myeloma who previously received 3 or more lines of therapy, including a proteasome inhibitor and an immunomodulatory drug.

Chunrui liLugui qiuTongji medical collegeChinese academy of medical science hematology hospitalChina national medical products administrationHuazhong university of science technologyNational medical products administrationChinese academyMedical science hematology hospitalTongji hospitalHuazhong universityEquecabtagene autoleucelCart cell therapyMultiple myelomaNational medical products administrationFumanba 1

IASO Bio and Innovent Announce the NMPA Approval of the New Drug Application for Equecabtagene Autoleucel, the World s First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed and/or Refrac

IASO Bio and Innovent Announce the NMPA Approval of the New Drug Application for Equecabtagene Autoleucel, the World s First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed and/or Refrac
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHong kongRhui zhouEquecabtagene autoleucelLugui qiuEli lillyAdimab incyteChunrui liJinghua zhangInnovent biologicsInnovent biologics incTongji medical collegeChinese academy of medical science hematology hospitalChina national medical products administrationMd anderson cancer centerHuazhong university of science technology